CAS 749863-29-4 | CAROM-011 : Carotegrast methyl
(World's Largest Pharmaceutical Supplier)

CAS 749863-29-4 is a chemical compound with the molecular formula C23H26FNO7S. It is also known as Dapagliflozin, which is a medication used to treat type 2 diabetes.

Dapagliflozin works by blocking the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which reduces glucose reabsorption and increases glucose excretion in urine. By lowering blood sugar levels, Dapagliflozin can help improve glycemic control in people with type 2 diabetes.

Dapagliflozin can be taken orally once daily, either alone or in combination with other anti-diabetic medications. It has been shown to be effective in reducing hemoglobin A1c levels, a measure of average blood glucose levels over time, as well as reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.

However, like all medications, Dapagliflozin can cause side effects such as urinary tract infections, genital yeast infections, and hypotension. In rare cases, it may also cause more serious side effects such as ketoacidosis or acute kidney injury.

It is important to note that Dapagliflozin should only be used under the guidance of a healthcare professional and in accordance with its prescribed dosage. It may not be suitable for all patients, particularly those with certain medical conditions such as severe renal impairment, and regular monitoring is necessary to ensure its effectiveness and safety.

In summary, CAS 749863-29-4 is a chemical compound with medical uses as a medication for type 2 diabetes. It is effective in lowering blood sugar levels and reducing the risk of cardiovascular events, but should be used with caution and under the guidance of a healthcare professional due to potential side effects.